Abstract
Malignant B cells from chronic lymphocytic leukemia (B-CLL) patients have a long survival in vivo, although, in culture, they spontaneously die by apoptosis. Here, we analyzed the capacity of accessory leukocytes to modulate apoptosis of B-CLL cells in vitro. To this end, we performed long-term cultures using total mononuclear cells (TMC) from B-CLL patients and TMC depleted from monocytes, NK cells and T lymphocytes (B-CLL cells). In all the patients studied (n = 25) the presence of accessory leukocytes markedly prolonged the survival of B-CLL cells. The anti-apoptotic effect was exerted by monocytes and, to a lesser degree, NK cells, partially through the release of soluble factors. Indeed, accessory leukocytes separated from leukemic cells by semipermeable membranes were still able to prolong B-CLL cell survival. By flow cytometric analysis we found that the protective effect of non-malignant cells was associated with delayed down-regulation of Bcl-2 expression on leukemic cells. By contrast, the expression of Fas and Fas ligand proteins was unchanged in most samples. Our findings suggest that monocytes and NK cells, by delaying leukemic cell apoptosis, may play a role in B-CLL cell accumulation in vivo.
Similar content being viewed by others
References
Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet JL . The French Cooperative Group on CLL. B-cell chronic lymphocytic leukemia: present status and future directions Blood 1991 78: 1901–1911
Hamblin TJ, Oscier DG . Chronic lymphocytic leukaemia: thenature of the leukaemic cell Blood Rev 1997 11: 119–128
Robertson LE, Plunkett W . Apoptotic cell death in chronic lymphocytic leukemia Leuk Lymphoma 1993 11: 71–73
Rowan S, Fisher DE . Mechanisms of apoptotic cell death Leukemia 1997 11: 457–465
Blagosklonny MV . Cell death beyond apoptosis Leukemia 2000 14: 1502–1508
Daniel PT . Dissecting the pathways to death Leukemia 2000 14: 2035–2044
Fadeel B, Orrenius S, Zhivotovsky B . The most unkindest cut of all: on multiple roles of mammalian caspases Leukemia 2000 14: 1514–1524
King D, Pringle JH, Hutchinson M, Cohen GM . Processing/activation of caspases, -3 and -7 and -8 but not caspase-2, in the induction of apoptosis in B-chronic lymphocytic leukemia cells Leukemia 1998 12: 1553–1560
Dyer MJS, Zani VJ, Lu WZ, O'Byrne A, Mould S, Chapman R, Heward JM, Kayano H, Jadayel D, Matutes E . BCL2 translocations in leukemias of mature B cells Blood 1994 83: 3682–3688
Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S, Wang HG, Zhang X, Bullrich F, Croce CM, Rai K, Hines J, Reed JC . Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses Blood 1998 91: 3379–3384
Pepper C, Hoy T, Bentley DP . Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance Br J Cancer 1997 76: 935–941
Mapara MY, Bargou R, Zugck C, Dohner H, Ustaoglu F, Jonker RR, Krammer PH, Dorken B . APO-1 mediated apoptosis or proliferation in human chronic B-lymphocytic leukemia: correlation with bcl-2 oncogene expression Eur J Immunol 1993 23: 702–708
Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV . Expression and function of the FAS antigen in B-chronic lymphocytic leukemia and hairy cell leukemia Leukemia 1995 9: 1227–1232
Tinhofer I, Marschitz I, Kos M, Henn T, Egle A, Villunger A, Greil R . Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia Blood 1998 91: 4273–4281
Sampalo A, Navas G, Medina F, Segundo C, Cámara C, Brieva JA . Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95–CD96L interaction Blood 2000 96: 3168–3174
Kitada S, Zapata JM, Andreeff M, Reed JC . Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukemia Br J Haematol 1995 106: 995–1004
Bosanquet AG, Bell PB, Rooney N . Effect of interleukin-2 on CD95 (Fas/APO-1) expression in fresh chronic lymphocytic leukaemia and mantle cell lymphoma cells: relationship to ex vivo chemoresponse Anticancer Res 1999 19: 5329–5334
Collins RJ, Verschuer LA, Harmon BV, Prentice RL, Pope JH, Kerr JF . Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro Br J Haematol 1989 71: 343–350
Nilsson J, Soderberg O, Nilsson K, Rosén A . Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells Blood 2000 95: 1420–1426
Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell'Aquila M, Kipps TJ . Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1 Blood 2000 96: 2655–2663
Lagneaux L, Delforge A, Bron D, De Bruyn C, Stryckmans P . Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells Blood 1998 91: 2387–2396
Kini AR, Kay NE, Peterson LC . Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia Leukemia 2000 14: 1414–1418
Mohle R, Failenschmid C, Bautz F, Kanz L . Overwxpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1) Leukemia 1999 13: 1954–1959
Panayiotidis P, Jones D, Ganeshaguru K, Foroni L, Hoffbrand AV . Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro Br J Haematol 1996 92: 97–103
Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M . IL-4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates bcl-2 expression J Exp Med 1992 176: 1319–1326
Mainou-Fowler T, Craig VA, Copplestone JA, Hamon MD, Prentice AG . Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4 Blood 1994 84: 2297–2304
Chaouchi N, Wallon C, Taieb J, Auffredou MT, Tertian G, Lemoine FM, Delfraissy JF, Vazquez A . Interferon-α-mediated prevention on in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc Clin Immunol Immunopathol 1994 73: 197–203
Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK . Interferon γ inhibits apoptotic cell death in B cell chronic lymphocytic leukemia J Exp Med 1993 177: 213–218
Francia de Celle P, Mariani S, Riera L, Stacchini A, Reato G, Foa R . Interleukin-8 induces the accumulation of B cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion Blood 1996 87: 4382–4389
Kulmburg P, Radke M, Digel W . Lymphotoxin-alpha is an autocrine growth factor for chronic lymphocytic leukemia B cells Leukemia 1998 12: 493–498
Tretter T, Schuler M, Schneller F, Brass U, Esswein M, Aman MJ, Huber C, Peschel C . Direct cellular interaction with activated CD4+ T cells overcomes hyporesponsiveness of B cell chronic lymphocytic leukemia in vitro Cell Immunol 1998 189: 41–50
Decker T, Flohr T, Trautmann P, Aman MJ, Holter W, Majdic O, Huber C, Peschel . Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia Blood 1995 86: 1115–1123
Kneitz C, Goller M, Wilhelm M, Mehringer C, Wohlleben G, Schimpl A, Tony HP . Inhibition of T cell/B cell interaction by B-CLL cells Leukemia 1999 13: 98–104
Gamberale R, Geffner JR, Trevani A, Chernavsky A, Scolnik M, Arrosagaray G, Sarmiento M, Giordano M . Immune complexes inhibit apoptosis of chronic lymphocytic leukaemia B cells Br J Haematol 1999 107: 870–876
Coligan JE, Kruibeed AM, Margulies DH, Shevach EM, Stroeber W . Morphological and biochemical assays of apoptosis Current Protocols in Immunology John Wiley and Sons: Bethesda, MD 1994 pp 3.17.1–3.17.6
Nicoletti I, Migliorati MC, Pagliacci C, Grignani F, Ricciardi C . A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry J Immunol Methods 1991 139: 271–279
Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN, Plunkett W . Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine Blood 1993 81: 143–150
Douglas RS, Capocasale RJ, Lamb RJ, Nowell PC, Moore JS . Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-β Blood 1997 89: 941–947
Schena M, Larsson LG, Gottardi D, Gaidano G, Carlsson M, Nilsson K, Caligaris-Cappio F . Growth and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells Blood 1992 79: 2981–2989
Osorio LM, De Santiago A, Aguilar-Santelises M, Mellstedt H, Jondal M . CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM Blood 1997 89: 2833–2839
Jurlander J . The cellular biology of B-cell chronic lymphocytic leukemia Crit Rev Oncol Hematol 1998 27: 29–52
De la Fuente MT, Casanova B, García-Gila M, Silva A, García-Pardo A . Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax Leukemia 1999 13: 266–274
Caligaris-Cappio F, Hamblin TJ . B-cell chronic lymphocytic leukemia: a bird of a different feather J Clin Oncol 1999 17: 399–408
Plate JM, Long BW, Kelkar SB . Role of beta2 integrins in the prevention of apoptosis induction in chronic lymphocytic leukemia B cells Leukemia 2000 14: 34–39
Fluckiger AC, Durand I, Banchereau J . Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemic cells J Exp Med 1994 179: 91–99
Jurlander J, Lai C, Tan J, Chou CC, Geisler CH, Schriber J, Blumrnson LE, Narula SK, Baumann H, Caligiuri MA . Characterization of interleukin-10 receptor expression Blood 1997 89: 4146–4152
Tangye SG, Raison RL . Human cytokines suppress apoptosis of leukaemic CD5+ B-cells and preserve expression of bcl-2 Immunol Cell Biol 1997 75: 127–135
Cordingley FT, Bianchi A, Hoffbrand AV, Reittie JE, Heslop HE, Vyakarnam A, Turner M, Meager A, Brenner MK . Tumor necrosis factor factor as an autocrine tumour growth factor for chronic B-cell malignancies Lancet 1988 1: 969–975
Kolb JP . Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia Leukemia 2000 14: 1685–1694
Zhao H, Dugas N, Mathiot C, Delmer A, Dugas B, Sigaux F, Kolb JP . B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity Blood 1998 92: 1031–1043
Brizard A, Morel F, Lecron JC, Dreyfus B, Brizard F, Barra A, Preud'homme JL . Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23 Leuk Lymphoma 1994 14: 311–319
Blagosklony MV . Unwinding the loop of Bcl-2 phosphorylation Leukemia 2001 15: 869–874
Findley HW, Zhou M . The clinical significance of Fas expression in leukemia: question and controversies Leukemia 1999 13: 147–149
Mainou-Fowler T, Craig VA, Copplestone AJ, Hamon MD, Prentice AG . Effect of anti-APO1 on spontaneous apoptosis of B-cells in chronic lymphocytic leukaemia: the role of bcl-2 and interleukin 4 Leuk Lymphoma 1995 19: 301–308
Wang D, Freeman GJ, Levine H, Ritz J, Robertson MJ . Role of the CD40 and CD95 (APO-1/Fas) antigens in the apotosis of human B-cells malgnancies Br J Haematol 1997 97: 409–417
Acknowledgements
We would like to thank Ms Selma Tolosa and Ms Nelly Villagra for their excellent technical assistance and Fundación de la Hemofilia for the use of the FACScan cytometer. This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Técnicas, Agencia-Foncyt, Buenos Aires University School of Medicine, Ministerio de Salud and Fundación Alberto J Roemmers.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gamberale, R., Geffner, J., Arrosagaray, G. et al. Non-malignant leukocytes delay spontaneous B-CLL cell apoptosis. Leukemia 15, 1860–1867 (2001). https://doi.org/10.1038/sj.leu.2402288
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402288
- Springer Nature Limited
Keywords
This article is cited by
-
Chaetoglobosin A preferentially induces apoptosis in chronic lymphocytic leukemia cells by targeting the cytoskeleton
Leukemia (2014)
-
CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients
Cancer Immunology, Immunotherapy (2013)
-
T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile
Cancer Immunology, Immunotherapy (2013)
-
The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells
Investigational New Drugs (2012)
-
Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity
Leukemia (2005)